FAKTOR OPTIONSSCHEIN - AMGEN | Real-time BOERSE MUENCHEN 12:45:10 02/07/2024 BST | ||
| 4.11 EUR | -0.72% |
|
| Current month | +2.22% | ||
| 1 month | -7.80% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 02/07/24 | 4.11 | -0.72% |
| 01/07/24 | 4.14 | +2.22% |
| 28/06/24 | 4.05 | -0.25% |
| 27/06/24 | 4.06 | +1.25% |
| 26/06/24 | 4.01 | +8.09% |
Real-time BOERSE MUENCHEN
Last update July 02, 2024 at 12:45 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD2VEG |
| ISIN | DE000HD2VEG8 |
| Date issued | 21/02/2024 |
| Strike | 388.8 $ |
| Maturity | Unlimited |
| Parity | 18.48 : 1 |
| Emission price | 10.32 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.73 € |
|---|---|
| Lowest since issue | 3.6 € |
| Spread | 0.02 € |
| Spread % | 0.48% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
311
USD
Average target price
316.4
USD
Spread / Average Target
+1.75%
- Stock Market
- Certificates
- Certificat
